BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

495 related articles for article (PubMed ID: 12757617)

  • 1. Costimulation through OX40 is crucial for induction of an alloreactive human T-cell response.
    Ukyo N; Hori T; Yanagita S; Ishikawa T; Uchiyama T
    Immunology; 2003 Jun; 109(2):226-31. PubMed ID: 12757617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ligation of OX40 (CD134) regulates graft-versus-host disease (GVHD) and graft rejection in allogeneic bone marrow transplant recipients.
    Blazar BR; Sharpe AH; Chen AI; Panoskaltsis-Mortari A; Lees C; Akiba H; Yagita H; Killeen N; Taylor PA
    Blood; 2003 May; 101(9):3741-8. PubMed ID: 12521997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Critical contribution of OX40 ligand to T helper cell type 2 differentiation in experimental leishmaniasis.
    Akiba H; Miyahira Y; Atsuta M; Takeda K; Nohara C; Futagawa T; Matsuda H; Aoki T; Yagita H; Okumura K
    J Exp Med; 2000 Jan; 191(2):375-80. PubMed ID: 10637281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockade of CD28-B7, but not CD40-CD154, prevents costimulation of allogeneic porcine and xenogeneic human anti-porcine T cell responses.
    Lee RS; Yamada K; Womer KL; Pillsbury EP; Allison KS; Marolewski AE; Geng D; Thall AD; Arn JS; Sachs DH; Sayegh MH; Madsen JC
    J Immunol; 2000 Mar; 164(6):3434-44. PubMed ID: 10706740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD28-independent induction of experimental autoimmune encephalomyelitis.
    Chitnis T; Najafian N; Abdallah KA; Dong V; Yagita H; Sayegh MH; Khoury SJ
    J Clin Invest; 2001 Mar; 107(5):575-83. PubMed ID: 11238558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional CD4 T cells after intercellular molecular transfer of 0X40 ligand.
    Baba E; Takahashi Y; Lichtenfeld J; Tanaka R; Yoshida A; Sugamura K; Yamamoto N; Tanaka Y
    J Immunol; 2001 Jul; 167(2):875-83. PubMed ID: 11441094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of rat OX40 ligand by monoclonal antibody.
    Satake Y; Akiba H; Takeda K; Atsuta M; Yagita H; Okumura K
    Biochem Biophys Res Commun; 2000 Apr; 270(3):1041-8. PubMed ID: 10772947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compromised OX40 function in CD28-deficient mice is linked with failure to develop CXC chemokine receptor 5-positive CD4 cells and germinal centers.
    Walker LS; Gulbranson-Judge A; Flynn S; Brocker T; Raykundalia C; Goodall M; Förster R; Lipp M; Lane P
    J Exp Med; 1999 Oct; 190(8):1115-22. PubMed ID: 10523609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blocking CD40 - CD154 and CD80/CD86 - CD28 interactions during primary allogeneic stimulation results in T cell anergy and high IL-10 production.
    Van Gool SW; Vermeiren J; Rafiq K; Lorr K; de Boer M; Ceuppens JL
    Eur J Immunol; 1999 Aug; 29(8):2367-75. PubMed ID: 10458748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retroviral transduction of acute myeloid leukaemia-derived dendritic cells with OX40 ligand augments their antigen presenting activity.
    Yanagita S; Hori T; Matsubara Y; Ishikawa T; Uchiyama T
    Br J Haematol; 2004 Feb; 124(4):454-62. PubMed ID: 14984494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD28-independent costimulation of T cells by OX40 ligand and CD70 on activated B cells.
    Akiba H; Oshima H; Takeda K; Atsuta M; Nakano H; Nakajima A; Nohara C; Yagita H; Okumura K
    J Immunol; 1999 Jun; 162(12):7058-66. PubMed ID: 10358148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ox40 costimulation enhances the development of T cell responses induced by dendritic cells in vivo.
    De Smedt T; Smith J; Baum P; Fanslow W; Butz E; Maliszewski C
    J Immunol; 2002 Jan; 168(2):661-70. PubMed ID: 11777959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A diametric role for OX40 in the response of effector/memory CD4+ T cells and regulatory T cells to alloantigen.
    Kinnear G; Wood KJ; Fallah-Arani F; Jones ND
    J Immunol; 2013 Aug; 191(3):1465-75. PubMed ID: 23817421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human CD34(+) blood cells induce T-cell unresponsiveness to specific alloantigens only under costimulatory blockade.
    Arpinati M; Terragna C; Chirumbolo G; Rizzi S; Urbini B; Re F; Tura S; Baccarani M; Rondelli D
    Exp Hematol; 2003 Jan; 31(1):31-8. PubMed ID: 12543104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engagement of OX40 enhances antigen-specific CD4(+) T cell mobilization/memory development and humoral immunity: comparison of alphaOX-40 with alphaCTLA-4.
    Evans DE; Prell RA; Thalhofer CJ; Hurwitz AA; Weinberg AD
    J Immunol; 2001 Dec; 167(12):6804-11. PubMed ID: 11739496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockade of multiple costimulatory receptors induces hyporesponsiveness: inhibition of CD2 plus CD28 pathways.
    Woodward JE; Qin L; Chavin KD; Lin J; Tono T; Ding Y; Linsley PS; Bromberg JS; Baliga P
    Transplantation; 1996 Oct; 62(7):1011-8. PubMed ID: 8878397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD4(+) and CD8(+) anergic T cells induced by interleukin-10-treated human dendritic cells display antigen-specific suppressor activity.
    Steinbrink K; Graulich E; Kubsch S; Knop J; Enk AH
    Blood; 2002 Apr; 99(7):2468-76. PubMed ID: 11895781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired primary immune response in type-1 diabetes. Functional impairment at the level of APCs and T-cells.
    Spatz M; Eibl N; Hink S; Wolf HM; Fischer GF; Mayr WR; Schernthaner G; Eibl MM
    Cell Immunol; 2003 Jan; 221(1):15-26. PubMed ID: 12742378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD4 T cell traffic control: in vivo evidence that ligation of OX40 on CD4 T cells by OX40-ligand expressed on dendritic cells leads to the accumulation of CD4 T cells in B follicles.
    Brocker T; Gulbranson-Judge A; Flynn S; Riedinger M; Raykundalia C; Lane P
    Eur J Immunol; 1999 May; 29(5):1610-6. PubMed ID: 10359115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of gp34 (OX40 ligand) and OX40 on human T cell clones.
    Takasawa N; Ishii N; Higashimura N; Murata K; Tanaka Y; Nakamura M; Sasaki T; Sugamura K
    Jpn J Cancer Res; 2001 Apr; 92(4):377-82. PubMed ID: 11346458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.